Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00960700
Other study ID # Rayner-630F
Secondary ID
Status Terminated
Phase N/A
First received August 17, 2009
Last updated February 7, 2013
Start date September 2009
Est. completion date August 2011

Study information

Verified date February 2013
Source Rayner Intraocular Lenses Limited
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics CommissionLithuania: State Medicine Control Agency - Ministry of Health
Study type Observational

Clinical Trial Summary

A multi-centre non-randomized clinical investigation to assess multifocal visual outcomes using different near additions, for the treatment of aphakia after cataract removal.


Recruitment information / eligibility

Status Terminated
Enrollment 52
Est. completion date August 2011
Est. primary completion date August 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age-related cataract patients undergoing cataract surgery where the cataractous lens has been removed by phacoemulsification, with circular tear capsulotomy, leaving the posterior capsule intact

- Patients requiring primary IOL implantation

- Patients with a potential corrected visual acuity of 20/40 or better on clinical assessment

- Patients with normal anterior segments - apart from cataracts

- Subjects with clear intraocular media other than cataract

Exclusion Criteria:

- Pre-existing pathology or physiology, which may be aggravated by the implant, or may render the implant ineffective and that could potentially cause future acuity losses to a level of 0.5 or 20/40 or worse in either eye. This includes the following:

- Microphthalmia

- Corneal decompensation or Endothelial Insufficiency

- Pseudo exfoliation

- High myopia

- Pars planitis

- Patient with greater than 1 dioptre of pre-operative corneal astigmatism

- Subjects who are expected to require retinal laser treatment

- Previous intraocular and/or corneal surgery

- History of uveitis, glaucoma, proliferative diabetic retinopathy or IDDM, pseudoexfoliation, macular degeneration that may affect potential best corrected visual acuity of 20/40 or better

- Operative complications of posterior capsular rupture, zonular dehiscence, incomplete continuous curvilinear capsulorhexis, severe iris /corneal trauma and inability to achieve secure placement in the designated location

- Subjects using a systemic medication that is known to cause ocular side effects

- Subjects participating in a concurrent clinical trial or if they have participated in an ophthalmology clinical trial within the last 30 days

- Subjects who have only one eye with potentially good vision

- Patients who are not willing to cooperate in the 6-months follow-up period

- Children under the age of 18 years

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
Visual Acuity
Assessment of visual acuity
Contrast sensitivity
Assessment of contrast sensitivity
Reading Speed
Assessment of reading speed
Procedure:
Eye Health
Examination of eye health through use of a slitlamp/ photography. Assessment of Intraocular Pressure.

Locations

Country Name City State
Germany Ruprecht- Karl Universitat Heidelberg Abteilung Augenheilkunde Heidelberg
Lithuania Eye Clinic and national Centre of Ophthalmology Kaunas

Sponsors (1)

Lead Sponsor Collaborator
Rayner Intraocular Lenses Limited

Countries where clinical trial is conducted

Germany,  Lithuania, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual acuity at distance and near 1 year No
Secondary Range of clear vision 1 year No
Secondary Reading speed 1 year No
Secondary Cntrast sensitivity 1 year No
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A

External Links